Skip to main content

Table 1 Demographics

From: Potential prognostic value of biomarkers in lavage, sputum and serum in a five year clinical follow-up of smokers with and without COPD

 

2006/2007 Complete cohort

2006/2007 Data for subjects studied in 2012

2012 Data

 

Healthy smokers (N = 23)

COPD smokers (N = 24)

Healthy smokers (N = 11)

COPD smokers (N = 13)

Healthy smokers (N = 11)

COPD smokers (N = 13)

Female/male

6/17

6/18

4/7

4/9

4/7

4/9

Age [years]a

54 (42, 65)

54 (46, 68)

56 (51, 61)

53 (50, 56)

60 (56, 66)

58 (55, 61)

BMI [kg/m2]

25.4 ± 2.5

25.3 ± 3.4

25.5 ± 1.8

24.4 ± 3.0

26.7 ± 3.0

25.5 ± 3.9

Pack-years &

34.0 (21.0)

48.0 (15.5)***

32.0 (21.0)

47.0 (15.0)

37.5 (16.8)

50.1 (16.7)

Cotinine (ng/mL)

1262 ± 722

1561 ± 968

1232 ± 548

1620 ± 748

867 ± 659

1585 ± 678

FEV1 [L]

3.8 ± 0.8

2.0 ± 0.3***

3.5 ± 0.6

2.0 ± 0.3

3.2 ± 0.5

1.5 ± 0.5

FEV1 % pred.

112.5 ± 14.1

60.5 ± 6.8***

114.9 ± 12.8

60.7 ± 5.5

109,6 ± 14.2

47.3 ± 15.0

FVC [L]

5.1 ± 1.0

4.2 ± 0.9**

4.7 ± 0.9

4.3 ± 0.8

4.5 ± 0.7

3.6 ± 0.8

FEV1/FVC [%]

75.4 ± 5.0

48.7 ± 7.4***

74.3 ± 5.1

48.2 ± 6.7

71.1 ± 4.2

41.0 ±11.7

pO2 [mm Hg]

82.9 ± 9.7

73.3 ± 5.3***

81.2 ± 9.2

75.1 ± 5.7

76.5 ± 7.4

69,2 ± 7.6

  1. In 2012: COPD smokers: 2 quit smoking, 2 reduced smoking; healthy smokers: 2 quit smoking, 1 reduced smoking.
  2. a:presented as mean (minimum, maximum), all other data is presented as mean ± SD, ** = p < 0.01, *** = p < 0.005 & median (IQR).